My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
money
Personal Finance
Financial Advisors
Credit Cards
Taxes
Retirement
Insurance
Auto
Vision
Life
Dental
Health
Medicare
Home
Life
Business
Pet
Investing
Stocks
How to Buy Stocks
Best Stock Brokers
How to Get Free Stocks
How to Buy Stocks on an iPhone
Best Stock Brokers for Beginners
Options
How to Trade Options
How to Buy Put Options
Best Brokers for Options Trading
ETFs
How Do ETFs Work?
How to Invest in ETFs
Best Brokers for ETFs
Mutual Funds
Futures
How to Trade Futures
Best Apps for Trading Futures in March 2025
Best Futures Trading Platforms for March 2025
IPOs
Bonds
How to Trade Bonds
What Are Municipal Bonds?
How to Buy Municipal Bonds
Best Brokers for Bonds
Index Funds
Forex
Best Forex Brokers
Prop Trading
Brokerage Reviews
Webull Review
Moomoo Review
EdgeClear Review
Robinhood Review
NinjaTrader Review 2025: Pros, Cons and Fees
Interactive Brokers Review 2025
Alternative Investing
Real Estate
Gold and Silver
Collectibles
Art
Coins
Mortgage
Rates
Calculator
Reviews
Purchase
Refinance
Self-Employed
Best HELOC Lenders
Cryptocurrency
How to Get Crypto
Free Bitcoin
How to Buy Crypto
How to Buy Bitcoin
How to Buy Bitcoin with a Credit Card in January 2025
Crypto Wallets
Best Crypto to Invest In
Ripple Price Prediction
Stellar Price Prediction
Shiba Inu Price Prediction
Crypto Exchange Reviews
Gemini Review
Kraken Review
Coinbase Review
3Commas Review
Menu
Education
Technology Courses
Investing Courses
Business Courses
B2B
Newsletters
Recent Small Cap News
NRIX
:
The FDA Has Granted Orphan Drug Designation To Nurix Therapeutics' Bexobrutideg (NX-5948) For The Treatment Of Waldenström Macroglobulinemia
PSTV
:
D. Boral Capital Initiates Coverage On Plus Therapeutics with Buy Rating, Announces Price Target of $9
CATX
:
Perspective, Therapeutics Has Dosed The First Patient In A New Cohort Of A Phase 1/2a Trial Evaluating The Safety Of [212Pb]VMT01, A Targeted Alpha-particle Therapy, In Patients With Histologically Confirmed Melanoma And Positive Melanocortin 1 Receptor Imaging Scan
TVTX
:
Travere Submits sNDA To FDA For Seeking Priority Review For Traditional Approval Of FILSPARI For Focal Segmental Glomerulosclerosis Treatment
SAIC
:
Science Applications Intl Revised FY26 Revenue Outlook To $7.60B-$7.75B From $7.55B-$7.75B (Vs. Cons. $7.644B), Adj. EPS To $9.10 - $9.30 From $8.90 - $9.10 (vs. Cons. Of $9.07)
Explore Company Profiles
KULR Tech Gr (ASE:KULR)
Verb Tech (NAS:VERB)
Braemar Hotels & Resorts (NYS:BHR)
VolitionRX (ASE:VNRX)
Safehold (NYS:SAFE)
Axos Financial (NYS:AX)
INmune Bio (NAS:INMB)
Lantern Pharma (NAS:LTRN)
Phunware (NAS:PHUN)
Yatra Online (NAS:YTRA)
Datasea (NAS:DTSS)
Tonix Pharmaceuticals (NAS:TNXP)
Esports Entertainment (PINX:GMBL)
ChromaDex (NAS:CDXC)
4Front Ventures (CNQ:FFNT)
Kubient (PINX:KBNT)
RIWI (TSX:RIWI)
Dyadic International (NAS:DYAI)
Avicanna (TSE:AVCN)
US Global Investors (NAS:GROW)
Actinium Pharma (ASE:ATNM)
Sorrento Therapeutics (PINX:SRNE)
Genprex (NAS:GNPX)
ShiftPixy (NAS:PIXY)
Fortress Biotech (NAS:FBIO)
Worksport (NAS:WKSP)
Annovis Bio (NYS:ANVS)
AYRO (NAS:AYRO)
Coro Global (PINX:CGLO)
Citius Pharmaceuticals (NAS:CTXR)
Amesite (NAS:AMST)
Khiron Life Sciences (TSX:KHRN.H)
BioSig Technologies (NAS:BSGM)
Can Fite Biofarma (TAE:CANF)
C-Com Satellite Systems (TSX:CMI)
Siyata Mobile (NAS:SYTA)
01 Communique Laboratory (TSX:ONE)
Thermal Energy Intl (TSX:TMG)